Drawing for WISTA

USPTO serial 79048971

WISTA

Reviewed by CopyMark Law Group

Reg. 3679872Status 404
Filing date
Status date
Registration date
Sep 8, 2009
Examiner
HOLTZ, ALLISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WISTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thad Chaloemtiarana

Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 South Wacker Drive, Suite 2900CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; first aid kits and diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditionsSECTION 71 - CANCELLED—
009Computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bioinformatics, clinical development and statistics, laboratory and diagnostic instruments, namely, computer software for use in the analysis and diagnosis of medical conditions; pre-recorded CD-ROMS and computer disks containing electronic publications, namely, test reports, magazines and manuals, and information in the fields of pre-clinical, clinical and pharmaceutical research and drug discovery and drug research; computer servers; pre-recorded magnetic data carriers and pre-recorded computer disks containing databases and information in the field of scientific, medical, drug, clinical, pharmaceutical, biological, biotechnical, bioinformatic and statistical researchSECTION 71 - CANCELLED—
010Medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; medical apparatus for introducing pharmaceutical preparations into the body, the foregoing for carrying out tests for genetic testing; medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and testsSECTION 71 - CANCELLED—
016Printed matter, namely, albums, almanacs, booklets, books, catalogues, hand books, journals, manuals, magazines, periodicals, newspapers, pamphlets and prospectuses, all in the fields of biology, biotechnology, drugs, medicines, chemical preparations, pharmaceuticals, bioinformatics and scientific design, development and research and medical laboratory researchSECTION 71 - CANCELLED—
035Retail store services featuring pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, scientific, measuring and teaching apparatus and instruments, computer software, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests, and printed matter, books, journals, magazines, leaflets, publications, printed tests, written reports in the field of medical and pharmaceutical researchSECTION 71 - CANCELLED—
042Medical, pharmaceutical, genetic, biological and biotechnology research; design, research and development of drugs, pharmaceuticals and medicines for others; laboratory and medical laboratory research and development of drugs, pharmaceuticals and medicines for others; scientific development research and consultation in the fields of synthetic chemistry, organic chemistry, medicinal chemistry, pharmacological chemistry, anorgic chemistry, analytical chemistry, biological chemistry, radiochemistry, data analysis, informatics, bio-informatics, chem-informatics, computer aided design, artificial intelligence, neural networks, statistics, mathematics, physics and biophysics; biological development research and consultation in the fields of anatomy, pharmacology, pharmacokinetics, physiology, pathophysiology, aetiology, genomics, genetics, biochemicals, toxicology, neurochemistry, cellular biology, molecular biology, proteomics, pharmacological genetics and metabonomics; scientific research and development services for clinical development in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; development of prognostic and diagnostic tools for others; providing research consultation and information in the fields of medical, pharmaceutical, genetic, biological, drug, clinical, statistical and biotechnological researchSECTION 71 - CANCELLED—
044Medical services featuring health assessment surveys; providing information and consultancy relating to the aforesaid medical servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 6, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 6, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 12, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 25, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 24, 2017INPCINVALIDATION PROCESSED—
Dec 15, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 15, 2016C71TCANCELLED SECTION 71—
Sep 10, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 26, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 26, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 26, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 8, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 8, 2010FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 11, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 8, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 27, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 23, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2009NPUBNOTICE OF PUBLICATION—
May 19, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 17, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 23, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 23, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2008ALIEASSIGNED TO LIE—
Sep 28, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 19, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2008RFNTREFUSAL PROCESSED BY IB—
Apr 3, 2008CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Mar 27, 2008CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Mar 20, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2008RFRRREFUSAL PROCESSED BY MPU—
Mar 20, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 19, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2008DOCKASSIGNED TO EXAMINER—
Feb 22, 2008NWAPNEW APPLICATION ENTERED—
Feb 21, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance